Inventaire - your friends and communities are your best library

Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version

এতে প্রকাশিত: International Journal of Clinical Oncology

তারিখে প্রকাশিত: 2008-10-23

মূল বিষয়: gastrointestinal stromal tumor

Cites articles 45

তারিখ

শিরোনাম

লেখকগণ

2008-02-01

Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033

Robert G. Maki, Michael C. Heinrich
2007-10-22

An enhanced risk-group stratification system for more practical prognostication of clinically malignant gastrointestinal stromal tumors
2007-03-01

Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.

Jean-Yves Blay, Axel Le Cesne, Isabelle Ray-Coquard, Florence Duffaud, Emmanuelle Bompas, Didier Cupissol, Jérôme Fayette, Antoine Adenis, Sylvie Chabaud, Cécile Guillemet, Catherine Delbaldo, Patrice Berthaud, David Pérol
2007-07-01

NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines

Alessandro Gronchi, Robert G. Maki, Ronald P DeMatteo, Paolo Giovanni Casali, Axel Le Cesne, Peter Hohenberger, Maria Debiec-Rychter, John Zalcberg
2007-03-01

Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST.

Alessandro Gronchi, Marco Fiore, Paolo Giovanni Casali, Silvana Pilotti
2007-06-27

Surgical interventions for focal progression of advanced gastrointestinal stromal tumors during imatinib therapy.
2007-03-01

Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor

Robert G. Maki, Samuel Singer, Murray Brennan, Ronald P DeMatteo
2006-09-05

Molecular correlates of imatinib resistance in gastrointestinal stromal tumors

Michael C. Heinrich, Heikki Joensuu, Christopher D. M. Fletcher
2006-04-01

Operative indications for relatively small (2-5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60 operated cases
2006-12-16

Surgical strategy for gastric gastrointestinal stromal tumors: laparoscopic vs. open resection
2006-02-21

Laparoscopic management of gastrointestinal stromal tumors
2006-06-01

Gastrointestinal stromal tumor (GIST) and imatinib
2006-06

Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors
2006-05-01

Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors

Chandrajit P Raut, Monica Bertagnolli, George D Demetri
2006-03-01

Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate.

Piotr Rutkowski, Anna Nasierowska-Guttmejer, Urszula Grzesiakowska, Zbigniew I Nowecki, Włodzimierz Ruka
2006-10-14

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

Paolo Giovanni Casali, Jayesh Desai, Grant McArthur, Michael C. Heinrich, Jaap Verweij, Christopher D. M. Fletcher, Ian Judson
2005-08-01

Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trial

Paolo Giovanni Casali, Axel Le Cesne, Rossella Bertulli, Raf Sciot, Peter Hohenberger, Jaap Verweij, Isabelle Ray-Coquard, Pancras C.W. Hogendoorn, Martine van Glabbeke, Ian Judson, Marcus Schlemmer, Allan T. van Oosterom
2005-11-01

Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib

Sebastian Bauer, Gerald Antoch
2005-02-01

PDGFRalpha- and c-kit-mutated gastrointestinal stromal tumours (GISTs) are characterized by distinctive histological and immunohistochemical features

Dietmar R. Thal
2005-04-01

Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO

Jean-Yves Blay, Paolo Giovanni Casali, Angelo Paolo Dei Tos, Alessandro Gronchi, Pancras C.W. Hogendoorn, Sigrid Stroobants
2005-05-01

Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling.

Ruth Birbe, Roland Dunbrack, Margaret von Mehren
2005-04-15

Gastrointestinal stromal tumor: new nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate
2005-08-01

Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg.

Axel Le Cesne, Jean-Yves Blay, Paolo Giovanni Casali, Jaap Verweij, Martine van Glabbeke, Ian Judson, Marcus Schlemmer, John Zalcberg, Peter Reichardt
2004-10-01

Gastrointestinal stromal tumors of the stomach: CT findings and prediction of malignancy.

Joon Koo Han, Jeong Min Lee
2004-12-01

CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings
2004-11-15

KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors

Harri Sihto, Heikki Joensuu, Maarit Sarlomo-Rikala, Olli Tynninen, Nina N Nupponen, Minna Tanner
2004-08-01

Endoscopic ultrasound-guided fine-needle aspiration biopsy: a powerful tool to obtain samples from small lesions
2004-09-01

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

Jean-Yves Blay, Rossella Bertulli, Paolo Giovanni Casali, Rolf D Issels, Jaap Verweij, Pancras C.W. Hogendoorn, John Zalcberg, Ian Judson
2004-01-01

The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors
2004-03-01

Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors

Andreas Bockisch, Gerald Antoch, Jörg Debatin
2003-01-09

PDGFRA activating mutations in gastrointestinal stromal tumors

Michael C. Heinrich, Anette Duensing, Samuel Singer
2003-12-01

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

Samuel Singer, Michael C. Heinrich, Brian Druker, Margaret von Mehren, Christopher D. M. Fletcher

নিবন্ধ - wd:Q46301106

জায়ে আপনাকে স্বাগত

the library of your friends and communities

আরো জানুন